Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-25 @ 4:13 PM
Study NCT ID:
NCT04857359
Status:
TERMINATED
Last Update Posted:
2025-08-06
First Post:
2021-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor:
Addex Pharma S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-21
First Submit QC Date:
None
Study First Post Date:
2021-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL